Imago BioSciences, Inc.
(NASDAQ GS: IMGO)
Rigrodsky Law, P.A. is investigating Imago BioSciences, Inc. (“Imago”) regarding possible breaches of fiduciary duties and other violations of law related to Imago’s agreement to be acquired by Merk Sharp & Dohme LLC. Under the terms of the agreement, Imago’s shareholders will receive $36.00 per share.